Consumer Reports’ recent exploration into American dietary supplement popularity and limited regulatory oversight reveals dangers to avoid and tips to guide your supplement choices. Among the publication’s recommendations is to look for the USP Verified mark. Learn more.
In the past three decades, an increasingly globalized medical marketplace has helped improve patient access to new medicines. Sadly, it has also provided an opportunity for more substandard, adulterated, and counterfeit medical products. This article explains the evolving role of the ICH in helping to tackle this problem through harmonization, and how USP is linked to the effort.
Over the past three decades, generic medicines have significantly increased patient access to quality treatment, while lowering healthcare costs in the United States. Learn how a new class of prescription drugs knows as biosimilars, offers the same hope of increased access and reduced costs.
The 69th World Health Assembly, took place in Geneva on May 23 – 28, 2016, and USP was honored to co-host a high level discussion on global public health and the SDGs (Sustainable Development Goals). This article captures parts of the conversation that took place not only in Geneva but via social media as well.
Today, many critical, life-saving medicines go through a complex global supply chain before ever reaching the patient. USP’s public standards play important roles throughout that supply chain. Learn more.
Over-the-counter (OTC) medicines, drugs available to consumers/patients without a prescription, play an important role in our modern healthcare system. An upcoming Consumer Healthcare Products Association workshop highlights how USP collaborates with key stakeholders to help address specific needs in OTC manufacturing and testing related to drug quality. Learn more.